Targeted delivery of an anti-inflammatory corticosteroid to Ly6C/G-positive cells abates severity of influenza A symptoms.
Proc Natl Acad Sci U S A
; 119(43): e2211065119, 2022 10 25.
Article
in En
| MEDLINE
| ID: mdl-36252038
Full text:
1
Database:
MEDLINE
Main subject:
Influenza, Human
/
Single-Domain Antibodies
Type of study:
Diagnostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Proc Natl Acad Sci U S A
Year:
2022
Type:
Article